Gottfried Novacek

7.6k total citations · 1 hit paper
103 papers, 3.3k citations indexed

About

Gottfried Novacek is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Gottfried Novacek has authored 103 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 48 papers in Epidemiology and 40 papers in Surgery. Recurrent topics in Gottfried Novacek's work include Inflammatory Bowel Disease (57 papers), Microscopic Colitis (38 papers) and Eosinophilic Esophagitis (19 papers). Gottfried Novacek is often cited by papers focused on Inflammatory Bowel Disease (57 papers), Microscopic Colitis (38 papers) and Eosinophilic Esophagitis (19 papers). Gottfried Novacek collaborates with scholars based in Austria, Germany and Canada. Gottfried Novacek's co-authors include Harald Vogelsang, Clemens Dejaco, Walter Reinisch, Simon Travis, Walter Reinisch, Jean–Frédéric Colombel, James O. Lindsay, Alastair Windsor, Séverine Vermeire and Miquel Sans and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Medicine.

In The Last Decade

Gottfried Novacek

96 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

2012 1.2k citations Axel Dignaß, James O. Lindsay et al. Journal of Crohn s and Colitis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gottfried Novacek Austria	26	1.8k	1.6k	1.2k	497	418	103	3.3k
Kim L. Isaacs United States	29	2.3k 1.3×	1.5k 1.0×	1.3k 1.1×	294 0.6×	521 1.2×	95	3.9k
Alfredo Papa Italy	36	1.9k 1.1×	1.4k 0.8×	1.4k 1.2×	279 0.6×	493 1.2×	161	3.9k
Sang Hyoung Park South Korea	37	2.5k 1.4×	2.0k 1.2×	1.7k 1.4×	320 0.6×	409 1.0×	252	4.5k
Mariangela Allocca Italy	33	2.0k 1.1×	1.6k 1.0×	1.1k 0.9×	271 0.5×	279 0.7×	177	3.3k
Timothy R. Orchard United Kingdom	24	2.7k 1.5×	2.0k 1.3×	1.1k 0.9×	213 0.4×	538 1.3×	51	4.0k
Gwo‐Tzer Ho United Kingdom	29	2.5k 1.4×	1.8k 1.1×	1.1k 0.9×	260 0.5×	747 1.8×	65	3.9k
Miguel Regueiro United States	25	2.4k 1.3×	1.8k 1.2×	1.3k 1.1×	220 0.4×	233 0.6×	184	3.4k
Eric A. Vasiliauskas United States	35	3.1k 1.7×	2.3k 1.5×	1.3k 1.1×	453 0.9×	327 0.8×	96	4.7k
Marcus Harbord United Kingdom	15	2.2k 1.2×	1.6k 1.0×	843 0.7×	200 0.4×	392 0.9×	26	3.0k
J F Colombel United States	29	2.2k 1.2×	1.7k 1.0×	1.4k 1.1×	162 0.3×	389 0.9×	148	3.6k

Countries citing papers authored by Gottfried Novacek

Since Specialization

Citations

This map shows the geographic impact of Gottfried Novacek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gottfried Novacek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gottfried Novacek more than expected).

Fields of papers citing papers by Gottfried Novacek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gottfried Novacek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gottfried Novacek. The network helps show where Gottfried Novacek may publish in the future.

Co-authorship network of co-authors of Gottfried Novacek

This figure shows the co-authorship network connecting the top 25 collaborators of Gottfried Novacek. A scholar is included among the top collaborators of Gottfried Novacek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gottfried Novacek. Gottfried Novacek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neumann, Luitgard M., Lili Kazemi-Shirazi, Michael Trauner, et al.. (2025). No increase of biopsy rates despite high rates of probable eosinophilic esophagitis in patients with esophageal food impaction. Wiener klinische Wochenschrift. 137(23-24). 768–773.

Novacek, Gottfried, et al.. (2025). Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis. Inflammatory Intestinal Diseases. 10(1). 155–160.

Tobudic, Selma, Elisabeth Simader, Felix Kartnig, et al.. (2023). The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination. Frontiers in Medicine. 10. 1049157–1049157. 5 indexed citations

Reider, Simon, Gottfried Novacek, Thomas Haas, et al.. (2023). Positionspapier der Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen der ÖGGH zum Einsatz von Vedolizumab subkutan. Zeitschrift für Gastroenterologie. 61(11). 1518–1525. 1 indexed citations

Primas, Christian, et al.. (2022). Induction Efficacy of Upadacitinib in Therapy-Refractory Crohn’s Disease: A Retrospective Case Series. Clinical Gastroenterology and Hepatology. 21(2). 532–534.e3. 4 indexed citations

Ritschl, Valentin, Berthold Reichardt, Tanja Stamm, et al.. (2022). Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. Journal of Clinical Medicine. 11(18). 5308–5308. 3 indexed citations

Ritschl, Valentin, et al.. (2022). Impact of Covid-19 pandemic on initiation of immunosuppressivetreatment in immune-mediated diseases–A nationwide, retrospectivestudy. Zeitschrift für Gastroenterologie. 60(8). e671–e671. 1 indexed citations

Teich, Niels, Wolfgang Mohl, Christian Primas, et al.. (2020). Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn’s disease: results from a large case–control study. Scandinavian Journal of Gastroenterology. 55(9). 1028–1034. 4 indexed citations

Wenzl, H, Christian Primas, Gottfried Novacek, et al.. (2014). Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease. Digestive Diseases and Sciences. 60(5). 1414–1423. 31 indexed citations

10.

Dignaß, Axel, James O. Lindsay, Andreas Sturm, et al.. (2012). Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. Journal of Crohn s and Colitis. 6(10). 991–1030. 1248 indexed citations breakdown →

11.

Novacek, Gottfried, Marietta Kollars, Gregor Hron, et al.. (2012). Tissue factor exposing microparticles in inflammatory bowel disease. Journal of Crohn s and Colitis. 7(3). 222–229. 22 indexed citations

12.

Eser, Alexander, Pavol Papay, Christian Primas, et al.. (2011). The impact of intestinal resection on serum levels of anti‐Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics. 35(2). 292–299. 12 indexed citations

13.

Reinisch, Walter, Thomas Haas, Arthur Kaser, et al.. (2009). Adalimumab in der Behandlung des Morbus Crohn – ein Konsensus der Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie. Zeitschrift für Gastroenterologie. 47(4). 372–380. 1 indexed citations

14.

Papay, Pavol, Walter Reinisch, Donata Lissner, et al.. (2008). W1131 Maintenance Therapy with Azathioprine (AZA)/6-Mercaptopurine (6-MP) in Crohn'sDisease (CD) Reduces the Risk of RE-Operation Particularly in Smokers. Gastroenterology. 134(4). A–640. 1 indexed citations

15.

Papay, Pavol, et al.. (2007). P033 AZATHIOPRINE/6-MERCAPTOPURINE (AZA/6-MP) REDUCES THE RISK OF INTESTINAL RE-OPERATION IN CROHN'S DISEASE (CD). 1(1). 12–12. 2 indexed citations

16.

Dilger, K., Dietmar Trenk, Martin Rössle, et al.. (2007). A clinical trial on absorption andN‐acetylation of oral and rectal mesalazine. European Journal of Clinical Investigation. 37(7). 558–565. 12 indexed citations

17.

Novacek, Gottfried. (2006). Gender and Gallstone Disease. Wiener Medizinische Wochenschrift. 156(19-20). 527–533. 109 indexed citations

18.

Novacek, Gottfried. (2006). Plummer-Vinson syndrome. Orphanet Journal of Rare Diseases. 1(1). 36–36. 108 indexed citations

19.

Novacek, Gottfried, Markus Haumer, Wolfgang Schima, et al.. (2004). Aortic Mural Thrombi in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 10(4). 430–435. 50 indexed citations

20.

Novacek, Gottfried, Stylianos Kapiotis, Gabriele Moser, et al.. (1997). No evidence of activated blood coagulation in Crohn??s disease. European Journal of Gastroenterology & Hepatology. 9(10). 963–967. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact